KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Long-Term Investments: 2014-2025

Historic Long-Term Investments for Quest Diagnostics (DGX) over the last 10 years, with Sep 2025 value amounting to $137.0 million.

  • Quest Diagnostics' Long-Term Investments rose 9.60% to $137.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $137.0 million, marking a year-over-year increase of 9.60%. This contributed to the annual value of $123.0 million for FY2024, which is 8.89% down from last year.
  • Quest Diagnostics' Long-Term Investments amounted to $137.0 million in Q3 2025, which was up 0.74% from $136.0 million recorded in Q2 2025.
  • Quest Diagnostics' Long-Term Investments' 5-year high stood at $527.0 million during Q1 2021, with a 5-year trough of $111.0 million in Q2 2021.
  • Over the past 3 years, Quest Diagnostics' median Long-Term Investments value was $133.0 million (recorded in 2024), while the average stood at $131.1 million.
  • In the last 5 years, Quest Diagnostics' Long-Term Investments plummeted by 77.58% in 2021 and then soared by 32.43% in 2022.
  • Quest Diagnostics' Long-Term Investments (Quarterly) stood at $141.0 million in 2021, then dropped by 6.38% to $132.0 million in 2022, then increased by 2.27% to $135.0 million in 2023, then decreased by 8.89% to $123.0 million in 2024, then grew by 9.60% to $137.0 million in 2025.
  • Its last three reported values are $137.0 million in Q3 2025, $136.0 million for Q2 2025, and $134.0 million during Q1 2025.